155 related articles for article (PubMed ID: 1930878)
1. Stereospecificity of the dopamine receptor mediating the growth hormone response to apomorphine in man. Short communication.
Lal S; Nair NP; Thavundayil JX; Tawar V; Quirion R; Guyda H
J Neural Transm Gen Sect; 1991; 85(2):157-64. PubMed ID: 1930878
[TBL] [Abstract][Full Text] [Related]
2. Effect of domperidone on apomorphine-induced growth hormone secretion in normal men.
Lal S; Nair NP; Iskandar HL; Etienne P; Wood PL; Schwartz G; Guyda H
J Neural Transm; 1982; 54(1-2):75-84. PubMed ID: 7108512
[TBL] [Abstract][Full Text] [Related]
3. Effect of hydrocortisone on basal and apomorphine-induced growth hormone secretion in normal subjects.
Lal S; Nair NP; Isaac I; Guyda H; Quirion R
Clin Invest Med; 1988 Jun; 11(3):218-23. PubMed ID: 3402107
[TBL] [Abstract][Full Text] [Related]
4. CCK-33 antagonizes apomorphine-induced growth hormone secretion and increases basal prolactin levels in man.
Nair NP; Lal S; Thavundayil JX; Wood PL; Etienne P; Guyda H
Neuropeptides; 1984 Jun; 4(4):281-91. PubMed ID: 6472582
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of dopamine agonists and haloperidol on release of prolactin, thyroid stimulating hormone, growth hormone and luteinizing hormone in rats.
Mueller GP; Simpkins J; Meites J; Moore KE
Neuroendocrinology; 1976; 20(2):121-35. PubMed ID: 958594
[TBL] [Abstract][Full Text] [Related]
6. Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion.
Lal S; Nair NP; Cervantes P; Pulman J; Guyda H
Acta Psychiatr Scand; 1979 Feb; 59(2):173-9. PubMed ID: 420037
[TBL] [Abstract][Full Text] [Related]
7. The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia.
Meltzer HY; Lee MA; Jayathilake K
Neuropsychopharmacology; 2001 Mar; 24(3):278-90. PubMed ID: 11166518
[TBL] [Abstract][Full Text] [Related]
8. Effect of some peptides on dopaminergic function in man.
Lal S; Nair NP; Isaac I; Thavundayil J; Guyda H
J Neural Transm Suppl; 1990; 29():173-81. PubMed ID: 2113567
[TBL] [Abstract][Full Text] [Related]
9. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
Ettigi P; Nair NP; Lal S; Cervantes P; Guyda H
J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808
[TBL] [Abstract][Full Text] [Related]
10. Effect of apomorphine on melatonin secretion in normal subjects.
Lal S; Isaac I; Pilapil C; Nair NP; Hariharasubramanian N; Guyda H; Quirion R
Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):229-33. PubMed ID: 3628830
[TBL] [Abstract][Full Text] [Related]
11. CCK-8 antagonizes apomorphine-induced growth hormone secretion in normal subjects.
Nair NP; Lal S; Eugenio H; Lizondo E; Thavundayil JX; Wood PL; Etienne P; Guyda H
Horm Metab Res; 1986 Jan; 18(1):53-5. PubMed ID: 3949282
[TBL] [Abstract][Full Text] [Related]
12. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
González LC; Pinilla L; Tena-Sempere M; Aguilar E
J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
[TBL] [Abstract][Full Text] [Related]
13. Effect of sulpiride, an atypical neuroleptic, on apomorphine-induced growth hormone secretion.
Nair NP; Lal S; Iskandar HI; Etienne P; Wood PL; Guyda H
Brain Res Bull; 1982 Jun; 8(6):587-91. PubMed ID: 7139355
[TBL] [Abstract][Full Text] [Related]
14. Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats.
Murugaiah K; Fleminger S; Hall MD; Theodorou A; Jenner P; Marsden CD
Neuropharmacology; 1984 Jun; 23(6):599-609. PubMed ID: 6540376
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine evaluation of CCK-peptides on dopaminergic function in man.
Lal S; Nair NP; Eugenio H; Thavundayil J; Lizondo E; Wood PL; Etienne P; Guyda H
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):537-44. PubMed ID: 6320299
[TBL] [Abstract][Full Text] [Related]
16. Increased striatal acetylcholine after 14 months cis-flupenthixol treatment in rats suggests functional supersensitivity of dopamine receptors.
Murugaiah K; Mann S; Theodorou AE; Jenner P; Marsden CD
Life Sci; 1982 Jul; 31(2):181-8. PubMed ID: 6889662
[TBL] [Abstract][Full Text] [Related]
17. Multihormonal responses to apomorphine in mental illness.
Mokrani MC; Duval F; Crocq MA; Bailey PE; Macher JP
Psychoneuroendocrinology; 1995; 20(4):365-75. PubMed ID: 8532820
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.
Meltzer HY; Kolakowska T; Fang VS; Fogg L; Robertson A; Lewine R; Strahilevitz M; Busch D
Arch Gen Psychiatry; 1984 May; 41(5):512-9. PubMed ID: 6721674
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine measures of dopaminergic function in chronic cocaine users.
Lee MA; Bowers MM; Nash JF; Meltzer HY
Psychiatry Res; 1990 Aug; 33(2):151-9. PubMed ID: 2243892
[TBL] [Abstract][Full Text] [Related]
20. Effect of flupenthixol and butaclamol isomers on prolactin secretion in rats.
Meltzer HY; Paul SM; Fang VS
Psychopharmacology (Berl); 1977 Jan; 51(2):181-3. PubMed ID: 14352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
